Finnish scientists ID link between GSK's swine flu vaccine and narcolepsy | WHAT REALLY HAPPENED

Finnish scientists ID link between GSK's swine flu vaccine and narcolepsy

Of the more than 30 million people in almost 50 countries who have received GlaxoSmithKline's ($GSK) Pandemrix, close to 800 have developed narcolepsy. And now, for the first time, a team from Finland thinks it knows why.

Comparing Pandemrix with Arepanrix, a vaccine used in Canada with the same adjuvant, the researchers found that Pandemrix had more of one structurally altered viral nucleoprotein--a disparity lead researcher Outi Vaarala attributed to the way the vaccines were prepared.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA